Clinical Trial Update: A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the tolerability, safety and efficacy of Paliperidone Extended Release in patients with schizophrenia. The results were posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-10-22